Search Results - "Balwierczak, J L"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Characterization of a potent and selective endothelin-B receptor antagonist, IRL 2500 by Balwierczak, J L, Bruseo, C W, DelGrande, D, Jeng, A Y, Savage, P, Shetty, S S

    “…IRL 2500 [N-(3,5-dimethylbenzoyl)-N-methyl-(D)-(4-phenylphenyl)-alany l-L- tryptophan] inhibited the binding of [125I]-endothelin-1 (ET-1) to human ETB (IC50…”
    Get more information
    Journal Article
  2. 2

    The relationship of KCl‐ and prostaglandin F2α‐mediated increases in tension of the porcine coronary artery with changes in intracellular Ca2+measured with fura‐2 by Balwierczak, Joseph L.

    Published in British journal of pharmacology (01-10-1991)
    “…1 Changes in intracellular free Ca2+concentration ([Ca2+]i) were measured simultaneously with changes in muscle tension by use of the fluorescent…”
    Get full text
    Journal Article
  3. 3

    Effects of metalloprotease inhibitors on smooth muscle endothelin-converting enzyme activity by BALWIERCZAK, J. L, KUKKOLA, P. J, SAVAGE, P, JENG, A. Y

    Published in Biochemical pharmacology (31-01-1995)
    “…The enzyme responsible for the conversion of exogenous big endothelin-1 to endothelin-1 by porcine coronary arterial smooth muscle has been shown to be a…”
    Get full text
    Journal Article
  4. 4

    Effects of adenosine A2 receptor agonists on nucleoside transport by Balwierczak, J L, Krulan, C M, Wang, Z C, Chen, J, Jeng, A Y

    “…A series of adenosine A2 receptor agonists were examined for their ability to activate adenosine A2 receptors and inhibit nucleoside transport. A2 receptor…”
    Get more information
    Journal Article
  5. 5

    The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma by Balwierczak, J L, Johnson, C L, Schwartz, A

    Published in Molecular pharmacology (01-02-1987)
    “…[3H]-d-cis-Diltiazem binds to canine cardiac sarcolemma in a specific, saturable, and reversible manner with a KD = 58.0 +/- 9.5 nM and a receptor site density…”
    Get more information
    Journal Article
  6. 6

    Effects of bepridil and diltiazem on [3H]nitrendipine binding to canine cardiac sarcolemma. Potentiation of pharmacological effects of nitrendipine by bepridil by Balwierczak, J L, Grupp, I L, Grupp, G, Schwartz, A

    “…[3H]Nitrendipine binds to canine cardiac sarcolemma in a specific, saturable and rapid manner. Bepridil, a Ca++ channel inhibitor, stimulates this binding at…”
    Get more information
    Journal Article
  7. 7

    Comparative effects of a selective adenosine A2 receptor agonist, CGS 21680, and nitroprusside in vascular smooth muscle by Balwierczak, J L, Sharif, R, Krulan, C M, Field, F P, Weiss, G B, Miller, M J

    Published in European journal of pharmacology (17-04-1991)
    “…CGS 21680 (2-[p-(2-carboxyethyl)phenylethylamino]-5'-N-ethyolcarboxamidoa denosine) is an adenosine agonist that has been reported recently to bind selectively…”
    Get more information
    Journal Article
  8. 8

    A simple assay for the measurement of conversion of big endothelin-1 to endothelin-1 by smooth muscle by Balwierczak, J L, Wong, M, Jeng, A Y

    Published in European journal of pharmacology (21-12-1993)
    “…The conversion of exogenous big endothelin-1 to endothelin-1 by the smooth muscle of denuded porcine coronary arterial strips was measured by radioimmunoassay…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    Decrease in immunoreactivity and vasoactivity of endothelin-1 after exposure to oxygen by Balwierczak, J L, Hopkins, M F, Savage, P, Martin, L L, Jeng, A Y

    Published in Biochemistry international (01-09-1992)
    “…Endothelin-1 (ET-1) caused a dose-dependent contraction of porcine coronary arterial rings. Preincubation of ET-1 in oxygenated Krebs solution at 37 degrees C…”
    Get more information
    Journal Article
  12. 12

    Two subtypes of the endothelin receptor (ETA and ETB) mediate vasoconstriction in the perfused rat heart by Balwierczak, J L

    “…The effects of endothelin-1 (ET-1) are mediated by two subclasses of the endothelin receptor, ETA and ETB. The Langendorff perfused rat heart was used to…”
    Get more information
    Journal Article
  13. 13

    Benzofused Macrocyclic Lactams as Triple Inhibitors of Endothelin-Converting Enzyme, Neutral Endopeptidase 24.11, and Angiotensin-Converting Enzyme by Ksander, Gary M, Savage, Paula, Trapani, Angelo J, Balwierczak, Joseph L, Jeng, Arco Y

    “…The purpose of this study was to identify endothelin-converting enzyme (ECE) inhibitors that also possess inhibitory activity for neutral endopeptidase 24.11…”
    Get full text
    Journal Article
  14. 14

    Different affinities and selectivities of endothelin-1 and endothelin-3 binding to various rat tissues by Jeng, A Y, Savage, P, Soriano, A, Balwierczak, J L

    Published in Biochemistry international (01-11-1990)
    “…Inhibition of [125I]endothelin-1 ([125I]ET-1) binding to membrane fractions from various rat tissues by ET-1 and endothelin-3 (ET-3) was investigated. Brain…”
    Get more information
    Journal Article
  15. 15

    Evidence that BKCa channel activation contributes to K+ channel opener induced relaxation of the porcine coronary artery by Balwierczak, J L, Krulan, C M, Kim, H S, DelGrande, D, Weiss, G B, Hu, S

    “…The rank order of potency of a series of benzopyran and cyanoguanidine K+ channel openers (KCOs) for causing relaxation of the PGF2 alpha-precontracted porcine…”
    Get full text
    Journal Article
  16. 16

    Purification and characterization of an endothelin degradation enzyme from rat kidney by Deng, A Y, Martin, L L, Balwierczak, J L, Jeng, A Y

    Published in Journal of biochemistry (Tokyo) (01-01-1994)
    “…A soluble protease which effectively inactivated endothelin-1 was purified 2,700-fold from rat kidney using DE52 anion exchange, concanavalin A-Sepharose,…”
    Get more information
    Journal Article
  17. 17

    Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1 by Trapani, A J, Balwierczak, J L, Lappe, R W, Stanton, J L, Graybill, S C, Hopkins, M F, Savage, P, Sperbeck, D M, Jeng, A Y

    “…The IC50 values of phosphoramidon, CGS 25015, CGS 26129, thiorphan and benazeprilat for inhibition of endothelin converting enzyme partially purified from…”
    Get more information
    Journal Article
  18. 18

    Dipeptide sulfonamides as endothelin ETA/ETB receptor antagonists by Ksander, Gary M, Shetty, Suraj S, DelGrande, Dominick, Balwierczak, Joseph L, Bruseo, Charles W, Savage, Paula, deJesus, Reynalda, Yuan, Andrew, Webb, Randy L, Jeng, Arco Y

    “…Endothelin-1 (ET-1) is a potent mitogen and modulator of vascular tone. It is synthesized and released from endothelial cells and acts upon two receptor…”
    Get more information
    Journal Article